… residual leukemic cells in ALL patients. The advent of novel techniques, namely next
generation flow cytometry (NGF), digital-droplet-PCR (ddPCR), and next generation sequencing (…

… Study Group for Adult Acute Lymphoblastic Leukemia. Clinical significance of minimal residual
disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.  …

… (which may include allogeneic stem cell transplantation) and to create risk profiles for
patients based on measured clearance of leukemic cells and post-treatment probability of …

… Patients with chronic lymphocytic leukemia (CLL) who achieve undetectable minimal residual
disease (U-MRD) (ie, < 10 -4 detectable leukemic cells in peripheral blood or bone marrow…

… ”) residual disease (MRD) in acute myeloid leukemia (AML). Although the perfect MRD test
does not (yet) exist, the strong association between MRD and adverse patient outcomes has …

… Residual Disease The rate at which ALL regresses after initiation of induction therapy varies
from patient to patient… Overall, patients with higher residual disease following treatment have …

… chemotherapy (FC or Chl or B) in TN or R/R CLL patients, a subgroup analysis of 158 TN
CLL patients receiving B+G was reported. ORR was 81.0%, with uMRD in 59.5% and 27.8% of …

… assessment improves prediction of outcome in patients with chronic lymphocytic leukemia
(CLL) who achieve partial response: comprehensive analysis of two-phase III studies of the …

… CH detected in AML patients in CR includes true residual or early recurrent AML,
myelodysplastic syndrome or CH that is ancestral to the AML, and independent or newly emerging …

… patients found better CIR and OS in patients with undetectable mutations compared with
those with residual … (482 patients, 54 genes), presence of any non-DTA leukemia-associated …